Coccinia indica is a creeper that grows wild and in abundance in Bengal. The plant has been used since ancient times for treating diabetes mellitus in the Indian system of medicine known as ayurvedha. 1 We report the findings of a double-blind controlled trial using the leaves of the plant to treat patients with untreated but uncomplicated maturity-onset diabetes.
Patients, methods, and results
Patients with diabetes mellitus attending the outpatient clinic of this institute were admitted at random to the trial if they gave informed consent.
Only patients with uncontrolled and untreated diabetes were considered suitable for the study. Patients with ketone bodies in their urine or those who were thought to need immediate treatment with insulin were excluded.
The patients received at random either tablets made from the homogenised and freeze-dried leaves of Coccinia indica or placebo tablets prepared with chlorophyll, and were told to take three tablets twice daily for six weeks. They were also told to continue on the same diet as before, and not to take any other medication. An oral glucose tolerance test (50 g) was done at the beginning and at the end of the trial and fasting blood glucose concentrations were estimated during the trial for all the patients. Two doctors, unaware of which treatment had been given, classified the results of blood glucose estimations as showing marked improvement, mild improvement, or no improvement. When glucose tolerance became normal or almost normal the patient was classified as "markedly improved." The two groups of patients were comparable in respect of age, sex, weight, and severity and duration of diabetes.
Out of the 16 patients who received the C indica tablets, glucose tolerance considerably improved in 10, while none of those taking placebo showed such an improvement. This difference is highly significant (X2 with Yates correction= 11-7, p <0-001). If patients who showed modest improvement are included, then 11 out of 16 in the group taking C indica tablets and three out of 16 on placebo showed improvement in glucose tolerance, a difference that is also highly significant (x2=9-9, p<0-01). The table shows the results of the glucose tolerance test in both groups of patients before and after treatment.
There was virtually no change in the following factors after treatment with either C indica tablets or placebo: weight, haemoglobin, differential and leucocyte counts, erythrocyte sedimentation rate, aspartate transaminase (SGOT), alanine transaminase (SGPT), urea, and serum concentrations of electrolytes. None of the patients showed renal injury.
Comment
This study shows that the leaves of C indica may be useful for the oral treatment of patients with maturity-onset diabetes mellitus, especially as there were no adverse effects during six weeks of use. This is not surprising because the plant is commonly used by the local Bengali population as a vegetable. The data show that the active principle is slow acting, since the maximum effect was obtained only after three weeks of treatment. Failure by some authors2 to show any hypoglycaemic activity of the plant may be due to the short-term nature of their experiments. Mukherjee et a13 showed that the plant had hypoglycaemic activity in alloxan-diabetic rats, concluding that the active principle of the plant may have insulin-like activity. Hyperglycaemia induced by somatotrophin and corticotrophin in albino rats can be reduced by parenteral administration of the alcoholic extract of the plant. Values given as the means ± SD.
